POLYMED.NS Balance Sheet
Poly Medicure Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:43
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹587.32 Cr. | ₹818.53 Cr. | ₹1,038.14 Cr. | ₹1,255.15 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹72.58 Cr. | ₹66.70 Cr. | ₹89.65 Cr. | ₹90.51 Cr. | CapitalWorkInProgress |
| Goodwill | ₹28.58 Cr. | ₹28.58 Cr. | ₹28.58 Cr. | ₹273.79 Cr. | Goodwill |
| Other Intangible Assets | ₹15.97 Cr. | ₹15.99 Cr. | ₹15.19 Cr. | ₹157.09 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹0.00 Cr. | ₹20.44 Cr. | ₹7.28 Cr. | ₹0.61 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹40.29 Cr. | ₹36.78 Cr. | ₹51.32 Cr. | ₹84.07 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹770.20 Cr. | ₹1,017.05 Cr. | ₹1,275.46 Cr. | ₹1,976.83 Cr. | NoncurrentAssets |
| Inventories | ₹208.65 Cr. | ₹221.03 Cr. | ₹285.57 Cr. | ₹433.84 Cr. | Inventories |
| Trade Receivables | ₹235.43 Cr. | ₹269.94 Cr. | ₹349.73 Cr. | ₹531.17 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹7.06 Cr. | ₹12.05 Cr. | ₹8.70 Cr. | ₹51.23 Cr. | CashAndCashEquivalents |
| Current Investments | ₹118.59 Cr. | ₹139.54 Cr. | ₹1,056.61 Cr. | ₹739.16 Cr. | CurrentInvestments |
| Other Current Assets | ₹53.59 Cr. | ₹51.19 Cr. | ₹65.58 Cr. | ₹103.45 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹807.01 Cr. | ₹841.63 Cr. | ₹1,917.00 Cr. | ₹1,941.73 Cr. | CurrentAssets |
| Total Assets | ₹1,577.21 Cr. | ₹1,858.67 Cr. | ₹3,192.45 Cr. | ₹3,918.57 Cr. | Assets |
| Equity Share Capital | ₹47.97 Cr. | ₹47.99 Cr. | ₹50.66 Cr. | ₹50.68 Cr. | EquityShareCapital |
| Other Equity | ₹1,193.65 Cr. | ₹1,422.07 Cr. | ₹2,714.99 Cr. | ₹3,055.49 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹1,241.63 Cr. | ₹1,470.05 Cr. | ₹2,765.66 Cr. | ₹3,106.17 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | N/A | ₹43.07 Cr. | NonControllingInterest |
| Total Equity | ₹1,241.63 Cr. | ₹1,470.05 Cr. | ₹2,765.66 Cr. | ₹3,149.24 Cr. | Equity |
| Long-term Borrowings | ₹17.50 Cr. | ₹1.09 Cr. | ₹0.00 Cr. | ₹52.09 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹42.28 Cr. | ₹37.38 Cr. | ₹56.63 Cr. | ₹193.80 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹128.93 Cr. | ₹169.13 Cr. | ₹177.65 Cr. | ₹289.53 Cr. | BorrowingsCurrent |
| Trade Payables | ₹92.31 Cr. | ₹95.60 Cr. | ₹86.42 Cr. | ₹122.67 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹32.85 Cr. | ₹28.39 Cr. | ₹28.98 Cr. | ₹56.43 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹293.30 Cr. | ₹351.24 Cr. | ₹370.17 Cr. | ₹575.52 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹1,577.21 Cr. | ₹1,858.67 Cr. | ₹3,192.45 Cr. | ₹3,918.57 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from POLYMED.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).